Senior ScientistLovelace Biomedical Research InstituteAlbuquerque, New Mexico, United States
Disclosure(s): No financial relationships to disclose
633 - Incidence and Outcomes of Pediatric Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients Under Surveillance and Not Under Surveillance for Human Adenovirus (HAdV) in the Post-HCT Period
Saturday, October 19, 20243:30 PM – 3:45 PM US PT